Crossmark

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients

Crossref DOI link: https://doi.org/10.1016/j.rmed.2014.07.011

Published Print: 2014-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wedzicha, Jadwiga A.

Dahl, Ronald

Buhl, Roland

Schubert-Tennigkeit, Agnes

Chen, Hungta

D'Andrea, Peter

Fogel, Robert

Banerji, Donald
Funding

Funding for this research was provided by:

Novartis
License Information

Text and Data Mining valid from 2014-10-01

Text and Data Mining valid from 2014-10-01

Version of Record valid from 2014-08-05
More Information

This article is maintained by: Elsevier

Article Title: Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients

Journal Title: Respiratory Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rmed.2014.07.011

Content Type: article

Copyright: Copyright © 2014 The Authors. Published by Elsevier Ltd.

Document is current

Any future updates will be listed below